<DOC>
	<DOC>NCT00000358</DOC>
	<brief_summary>The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.</brief_summary>
	<brief_title>Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Lofexidine</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Please contact site for information.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>December 2002</verification_date>
</DOC>